The Reasons Behind The Selloff In Biotech Stocks And Subsequent Decline In The Nasdaq

April 8, 2014 3:11 AM

16 0

The Reasons Behind The Selloff In Biotech Stocks And Subsequent Decline In The Nasdaq

The market is correcting, and the valuations of biotech stocks seem to be adjusting to fairer levels. Here's what we think is going on

In the past one month, biotech stocks have taken a protracted tumble, pulled under by the poor performing, volatile stocks of small-cap companies that have yet to generate their first revenues. Valuations have also been hit by a Congressional inquisition in Gilead Sciences's (GILD) pricing practices...

Read more

To category page

Loading...